Clinical trial
The Efficacy and Safety of Pivmecillinam in Treating Bacteriemic Urosepsis Caused by E.Coli
NCT03282006 is registered in ClinicalTrials.gov with Sykehuset i Vestfold HF as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Pivmecillinam in Treating Bacteriemic Urosepsis Caused by E.Coli
- Lead sponsor
- Sykehuset i Vestfold HF
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 29, 2017
- Completion date
- April 21, 2020
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.